Total Payments
$4,288
2024 Payments
$49.52
Companies
24
Transactions
306
Medicare Patients
2,055
Medicare Billing
$244,448
Payment Breakdown by Category
Food & Beverage$4,248 (99.1%)
Education$39.55 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,248 | 299 | 99.1% |
| Education | $39.55 | 7 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $739.64 | 46 | $0 (2019) |
| GlaxoSmithKline, LLC. | $489.88 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $473.75 | 36 | $0 (2024) |
| PFIZER INC. | $393.03 | 37 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $317.02 | 18 | $0 (2024) |
| Lilly USA, LLC | $294.93 | 26 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $289.34 | 20 | $0 (2020) |
| Synergy Pharmaceuticals Inc | $185.79 | 16 | $0 (2018) |
| Novo Nordisk Inc | $168.31 | 12 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $154.73 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.52 | 3 | Merck Sharp & Dohme LLC ($18.83) |
| 2023 | $142.44 | 6 | Janssen Pharmaceuticals, Inc ($81.53) |
| 2022 | $109.40 | 5 | Novartis Pharmaceuticals Corporation ($56.43) |
| 2021 | $12.48 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($12.48) |
| 2020 | $73.05 | 5 | Allergan, Inc. ($17.84) |
| 2019 | $1,312 | 89 | AstraZeneca Pharmaceuticals LP ($285.40) |
| 2018 | $1,418 | 100 | AstraZeneca Pharmaceuticals LP ($293.38) |
| 2017 | $1,171 | 97 | Merck Sharp & Dohme Corporation ($188.46) |
All Payment Transactions
306 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: VACCINE | ||||||
| 03/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: VACCINES | ||||||
| 02/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/05/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/05/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/23/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/16/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $44.93 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/06/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/29/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/23/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $39.90 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/17/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/12/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: DIABETES | ||||||
| 02/11/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: RESPIRATORY | ||||||
| 01/07/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, BELSOMRA | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/20/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/13/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: DIABETES | ||||||
| 12/02/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: DIABETES | ||||||
| 11/25/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 368 | 686 | $271,285 | $53,121 |
| 2022 | 6 | 433 | 846 | $267,848 | $53,962 |
| 2021 | 6 | 524 | 1,040 | $299,664 | $64,385 |
| 2020 | 10 | 730 | 1,204 | $314,795 | $72,981 |
Total Patients
2,055
Total Services
3,776
Medicare Billing
$244,448
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 137 | 385 | $121,275 | $23,806 | 19.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 118 | $51,644 | $11,065 | 21.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 43 | 45 | $50,490 | $7,603 | 15.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 67 | 70 | $25,060 | $6,294 | 25.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 55 | 56 | $15,904 | $3,482 | 21.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 12 | $6,912 | $871.48 | 12.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 154 | 458 | $137,148 | $25,915 | 18.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 71 | 161 | $67,222 | $13,110 | 19.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 73 | 77 | $26,209 | $6,579 | 25.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 72 | 76 | $20,596 | $4,257 | 20.7% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 38 | 49 | $9,898 | $2,756 | 27.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 25 | 25 | $6,775 | $1,345 | 19.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 210 | 662 | $189,332 | $37,814 | 20.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 110 | 115 | $37,375 | $9,618 | 25.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 77 | $30,723 | $6,500 | 21.2% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 71 | 90 | $17,370 | $5,018 | 28.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 52 | 52 | $13,468 | $2,985 | 22.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 44 | 44 | $11,396 | $2,450 | 21.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 213 | 572 | $156,156 | $33,358 | 21.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 152 | 165 | $51,150 | $13,880 | 27.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 56 | 120 | $45,600 | $10,052 | 22.0% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 55 | 71 | $13,064 | $4,155 | 31.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 67 | 68 | $16,796 | $3,875 | 23.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 32 | 32 | $7,904 | $1,866 | 23.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 49 | 53 | $6,832 | $1,691 | 24.7% |
About Dr. Agnes Enrico-Simon, MD
Dr. Agnes Enrico-Simon, MD is a Family Medicine healthcare provider based in Pt Pleasant, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003910670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Agnes Enrico-Simon, MD has received a total of $4,288 in payments from pharmaceutical and medical device companies, with $49.52 received in 2024. These payments were reported across 306 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,248).
As a Medicare-enrolled provider, Enrico-Simon has provided services to 2,055 Medicare beneficiaries, totaling 3,776 services with total Medicare billing of $244,448. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Pt Pleasant, WV
- Active Since 09/12/2006
- Last Updated 02/19/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003910670
Products in Payments
- JANUVIA (Drug) $386.39
- FARXIGA (Drug) $379.47
- XARELTO (Drug) $317.02
- TRULICITY (Drug) $227.48
- JARDIANCE (Drug) $222.50
- SYMBICORT (Drug) $211.30
- TRELEGY ELLIPTA (Drug) $206.02
- ANORO (Drug) $200.42
- CHANTIX (Drug) $187.57
- Trulance (Drug) $185.79
- BEVESPI AEROSPHERE (Drug) $134.87
- ENTRESTO (Drug) $117.84
- Victoza (Drug) $108.71
- LifeVest (Device) $107.09
- VIAGRA (Drug) $98.99
- TOUJEO (Drug) $91.02
- LINZESS (Drug) $68.33
- Prolia (Biological) $57.54
- BREO (Drug) $55.43
- STIOLTO RESPIMAT (Drug) $47.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.